Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W2PQ
|
|||
| Former ID |
DNC006035
|
|||
| Drug Name |
4-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide
|
|||
| Synonyms |
CHEMBL200958
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H13BrN2O3
|
|||
| Canonical SMILES |
C=CC(=O)NC1=CC(=C(C=C1)C(=O)NC2=CC(=CC=C2)Br)O
|
|||
| InChI |
1S/C16H13BrN2O3/c1-2-15(21)18-12-6-7-13(14(20)9-12)16(22)19-11-5-3-4-10(17)8-11/h2-9,20H,1H2,(H,18,21)(H,19,22)
|
|||
| InChIKey |
RVPAGQILSYDDNT-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Acryloylamino-salicylanilides as EGFR PTK inhibitors. Bioorg Med Chem Lett. 2006 Jan 15;16(2):469-72. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.